Table 3: Number of Cases, Percent and Age-Specific Incidence Rate* (ASIR) of First Primary Central Nervous System Tumors among Children, Adolescents and Teens by Diagnositic Group, Age Group and Tumor Behavior, California, 2001-2005

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

< 5 years

 

5-9 years

 

 

Malignant

 

Benign

 

Uncertain

 

Total

 

Malignant

 

Benign

 

Uncertain

 

Total

Diagnostic Groups

 

n

%

ASIR

95% CI

 

n

%

ASIR

95% CI

 

n

%

 

n

%

 

n

%

ASIR

95% CI

 

n

%

ASIR

95% CI

 

n

%

 

n

%

IIIA  Ependymomas & Choroid Plexus Tumor

 

74

21.8%

 

 

 

21

13.6%

0.2

(0.1, 0.2)

 

 

 

 

99

18.1%

 

28

9.4%

0.2

(0.1, 0.3)

 

11

7.4%

 

 

 

6

9.2%

 

45

8.8%

IIIB  Astrocytomas

 

67

19.8%

0.8

(0.6, 0.9)

 

119

77.3%

0.9

(0.8,1.1)

 

 

 

 

189

34.6%

 

72

24.2%

1.0

(0.9, 1.2)

 

102

68.9%

0.8

(0.6, 0.9)

 

8

12.3%

 

182

35.7%

IIIC1  Medulloblastomas

 

64

18.9%

0.5

(0.4, 0.6)

 

0

0.0%

 

 

 

0

0.0%

 

64

11.7%

 

68

22.9%

0.5

(0.4, 0.7)

 

0

0.0%

 

 

 

0

0.0%

 

68

13.3%

IIIC2  PNET

 

47

13.9%

0.4

(0.3, 0.5)

 

0

0.0%

 

 

 

0

0.0%

 

47

8.6%

 

29

9.8%

0.2

(0.1, 0.3)

 

0

0.0%

 

 

 

0

0.0%

 

29

5.7%

IIIC9  Other Intracranial & Intraspinal

 

18

5.3%

0.1

(0.1, 0.2)

 

0

0.0%

 

 

 

0

0.0%

 

18

3.3%

 

 

 

 

 

 

0

0.0%

 

 

 

0

0.0%

 

 

 

IIID  Other Gliomas

 

40

11.8%

0.4

(0.3, 0.5)

 

0

0.0%

 

 

 

0

0.0%

 

40

7.3%

 

73

24.6%

0.6

(0.5, 0.8)

 

0

0.0%

 

 

 

0

0.0%

 

73

14.3%

IIIE  Other Specified Intracranial & Intraspinal

 

 

 

 

 

 

 

 

 

 

 

36

66.7%

 

43

7.9%

 

 

 

 

 

 

22

14.9%

0.2

(0.1, 0.3)

 

46

70.8%

 

71

13.9%

XA  Intracranial & Intraspinal Germ Cell

 

8

2.4%

 

 

 

5

3.2%

 

 

 

0

0.0%

 

13

2.4%

 

13

4.4%

 

 

 

 

 

 

 

 

0

0.0%

 

14

2.7%

Z  Other

 

17

5.0%

 

 

 

6

3.9%

 

 

 

11

20.4%

 

34

6.2%

 

9

3.0%

 

 

 

12

8.1%

 

 

 

5

7.7%

 

26

5.1%

Total

 

339

100.0%

2.6

(2.4, 2.9)

 

154

100.0%

1.2

(1.0, 1.4)

 

54

100.0%

 

547

100.0%

 

297

100.0%

2.3

(2.0, 2.5)

 

148

100.0%

1.1

(1.0, 1.3)

 

65

100.0%

 

510

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10-14 years

 

15-19 years

IIIA  Ependymomas & Choroid Plexus Tumor

 

23

9.0%

0.2

(0.1, 0.3)

 

5

3.1%

 

 

 

12

15.8%

 

40

8.1%

 

21

9.4%

0.2

(0.1, 0.2)

 

 

 

 

 

 

12

13.5%

 

37

6.8%

IIIB  Astrocytomas

 

66

25.9%

0.7

(0.6, 0.9)

 

89

55.6%

0.7

(0.5, 0.8)

 

7

9.2%

 

162

33.0%

 

71

31.8%

0.6

(0.5, 0.8)

 

61

25.8%

0.5

(0.4, 0.6)

 

5

5.6%

 

137

25.0%

IIIC1  Medulloblastomas

 

28

11.0%

0.2

(0.1, 0.3)

 

0

0.0%

 

 

 

0

0.0%

 

28

5.7%

 

23

10.3%

0.2

(0.1, 0.3)

 

0

0.0%

 

 

 

0

0.0%

 

23

4.2%

IIIC2  PNET

 

17

6.7%

0.1

(0.1, 0.2)

 

0

0.0%

 

 

 

0

0.0%

 

17

3.5%

 

11

4.9%

 

 

 

0

0.0%

 

 

 

0

0.0%

 

11

2.0%

IIIC9  Other Intracranial & Intraspinal

 

0

0.0%

 

 

 

0

0.0%

 

 

 

0

0.0%

 

0

0.0%

 

0

0.0%

 

 

 

0

0.0%

 

 

 

0

0.0%

 

0

0.0%

IIID  Other Gliomas

 

51

20.0%

0.4

(0.3, 0.5)

 

0

0.0%

 

 

 

0

0.0%

 

51

10.4%

 

35

15.7%

0.3

(0.2, 0.4)

 

0

0.0%

 

 

 

0

0.0%

 

35

6.4%

IIIE  Other Specified Intracranial & Intraspinal

 

 

 

 

 

 

41

25.6%

0.3

(0.2, 0.4)

 

46

60.5%

 

91

18.5%

 

6

2.7%

 

 

 

138

58.5%

1.1

(0.9, 1.3)

 

56

62.9%

 

200

36.5%

XA  Intracranial & Intraspinal Germ Cell

 

59

23.1%

0.4

(0.3, 0.6)

 

 

 

 

 

 

0

0.0%

 

62

12.6%

 

43

19.3%

0.3

(0.2, 0.4)

 

 

 

 

 

 

0

0.0%

 

45

8.2%

Z  Other

 

7

2.7%

 

 

 

22

13.8%

 

 

 

11

14.5%

 

40

8.1%

 

13

5.8%

 

 

 

31

13.1%

 

 

 

16

18.0%

 

60

10.9%

Total

 

255

100.0%

1.9

(1.6, 2.1)

 

160

100.0%

1.2

(1.0, 1.4)

 

76

100.0%

 

491

100.0%

 

223

100.0%

1.7

(1.5, 2.0)

 

236

100.0%

1.8

(1.6, 2.1)

 

89

100.0%

 

548

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* Age-specific incidence rates are per 100,000 population.  Rates are standardized to the 2000 US population.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PNET = Primitive Neuroectodermal Tumors

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shaded cells = rates could not be calculated if number of cases were less than 15 and/or the underlying population was less than 100,000.